{
  "image_filename": "table_p3_det_2_009.png",
  "image_path": "Treanor_et_al.__2011_/extracted/figures/table_p3_det_2_009.png",
  "image_type": "Table",
  "page_number": 3,
  "block_id": "det_2_009",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "Excerpt of a table showing counts and percentages of solicited adverse events (e.g., fever, fatigue, muscle pain, headache) by treatment group, with footnotes indicating severity grades and a sample size description referring to FluBlok and placebo randomization. does not support the claim because the table presents safety data comparing FluBlok to placebo and does not mention or compare against Fluarix quadrivalent standard-dose vaccine Note: Column headings are not visible and image is partially cut off, but no reference to Fluarix was observed",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Excerpt of a table showing counts and percentages of solicited adverse events (e.g., fever, fatigue, muscle pain, headache) by treatment group, with footnotes indicating severity grades and a sample size description referring to FluBlok and placebo randomization.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table presents safety data comparing FluBlok to placebo and does not mention or compare against Fluarix quadrivalent standard-dose vaccine",
    "confidence_notes": "Column headings are not visible and image is partially cut off, but no reference to Fluarix was observed"
  }
}